Entrada Therapeutics, Inc. (TRDA) — Stock Score Summary

Entrada Therapeutics, Inc. (TRDA) has a MoatMap StockRank of 15/100 based on Quality (28/100), Value (41/100), and Momentum (31/100) factor scores. The current signal is STRONG SELL.

Entrada Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing intracellular biologics using its proprietary Endosomal Escape Vehicle (EEV™) platform. The company aims to deliver therapeutics directly into the cytoplasm of cells, addressing a wide range of diseases that are currently untreatable by conventional biologics. Its innovative EEV platform provides a significant competitive differentiator by enabling access to novel intracellular drug targets.

Key Financial Metrics

Price$6.63
Market Cap$255M
P/E (Forward)-1.97
Price/Book0.79
Return on Equity-48.3%
Return on Invested Capital-44.7%
Debt/Equity18.37
Gross Margin0.0%
Operating Margin-4834.6%
Revenue Growth-95.7%
Free Cash Flow$-75M

Entrada Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Entrada Therapeutics, Inc.’s (TRDA) StockRank?
MoatMap’s StockRank for Entrada Therapeutics, Inc. (TRDA) is 15/100, with a Strong Sell signal. It is a composite of Quality (28), Value (41), and Momentum (31) factor ranks across MoatMap’s 19,000+ stock universe.
Does Entrada Therapeutics, Inc. have an economic moat?
Entrada Therapeutics, Inc. (TRDA) has a Quality factor score of 28/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Entrada Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Entrada Therapeutics, Inc. (TRDA) is Strong Sell, based on a StockRank of 15/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Entrada Therapeutics, Inc. in?
Entrada Therapeutics, Inc. (TRDA) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksTRDA deep dive reportAI ChampionsHow we score stocksSense-check another stock